Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
52,842,225
-
Share change
-
+601,122
-
Total reported value
-
$6,798,751,692
-
Put/Call ratio
-
69%
-
Price per share
-
$128.65
-
Number of holders
-
318
-
Value change
-
+$110,623,345
-
Number of buys
-
143
-
Number of sells
-
179
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2014
As of 30 Sep 2014,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
318 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,842,225 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, SCOPIA CAPITAL MANAGEMENT LLC, LSV ASSET MANAGEMENT, BlackRock Fund Advisors, AJO, LP, BlackRock Advisors LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., and DEUTSCHE BANK AG\.
This page lists
316
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.